T. Rowe Price Associates’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-5,451,998
Closed -$67.8M 2633
2016
Q4
$67.8M Sell
5,451,998
-567,990
-9% -$7.07M 0.01% 709
2016
Q3
$82.4M Buy
6,019,988
+5,945,688
+8,002% +$81.4M 0.02% 632
2016
Q2
$549K Hold
74,300
﹤0.01% 1925
2016
Q1
$475K Buy
74,300
+11,900
+19% +$76.1K ﹤0.01% 1993
2015
Q4
$390K Buy
62,400
+400
+0.6% +$2.5K ﹤0.01% 2061
2015
Q3
$362K Hold
62,000
﹤0.01% 2077
2015
Q2
$513K Hold
62,000
﹤0.01% 1986
2015
Q1
$511K Buy
62,000
+14,500
+31% +$120K ﹤0.01% 1962
2014
Q4
$326K Hold
47,500
﹤0.01% 2137
2014
Q3
$257K Hold
47,500
﹤0.01% 2220
2014
Q2
$303K Hold
47,500
﹤0.01% 2174
2014
Q1
$383K Hold
47,500
﹤0.01% 2030
2013
Q4
$324K Sell
47,500
-469,500
-91% -$3.2M ﹤0.01% 2106
2013
Q3
$9.51M Sell
517,000
-758,250
-59% -$14M ﹤0.01% 1282
2013
Q2
$22.3M Buy
+1,275,250
New +$22.3M 0.01% 1037